Inactivated vaccines articles within Scientific Reports

Featured

• Article
  18 November 2023 | Open Access

  Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

  • Niloofar Najafi
  • , Hoorieh Soleimanjahi
  •  & Zeynab Nasiri

• Article
  30 October 2023 | Open Access

  Phosphatidylinositolmannoside vaccination induces lipid-specific Th1-responses and partially protects guinea pigs from Mycobacterium tuberculosis challenge

  • Emmelie Eckhardt
  • , Jan Schinköthe
  •  & Max Bastian

• Article
  02 September 2023 | Open Access

  Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study

  • Alexander Winkelmann
  • , Christoph Metze
  •  & Micha Loebermann

• Article
  21 March 2023 | Open Access

  Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination

  • Ece Tavukcuoglu
  • , Hamdullah Yanik
  •  & Gunes Esendagli

• Article
  26 October 2022 | Open Access

  Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases

  • Yi-Qing Zheng
  • , He-Jun Li
  •  & Shun-Ping Lin

• Article
  27 September 2022 | Open Access

  High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test

  • Minetaro Arita
  •  & Masae Iwai-Itamochi

• Article
  04 August 2022 | Open Access

  Transcriptome and proteome analysis of innate immune responses to inactivated Leptospira and bivalent Leptospira vaccines in canine 030-D cells

  • Andreja Novak
  • , Jeroen L. A. Pennings
  •  & Arjen Sloots

• Article
  04 July 2022 | Open Access

  Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans

  • Mariem Gdoura
  • , Fatma Ben Ghaloum
  •  & Chokri Bahloul

• Article
  02 December 2021 | Open Access

  Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and influenza virus infection as assessed in a nationwide survey

  • Shingo Ishimori
  • , Takashi Ando
  •  & Kenji Ishikura

• Article
  26 February 2020 | Open Access

  Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection

  • Ginger Young
  • , Kelly J. Bohning
  •  & Hansi J. Dean

• Article
  07 November 2019 | Open Access

  Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice

  • Eita Sasaki
  • , Hideki Kusunoki
  •  & Isao Hamaguchi

• Article
  30 October 2019 | Open Access

  Responses to Quadrivalent Influenza Vaccine Reveal Distinct Circulating CD4+CXCR5+ T Cell Subsets in Men Living with HIV

  • Megan E. Cole
  • , Zainab Saeed
  •  & Katrina M. Pollock

• Article
  18 March 2019 | Open Access

  A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans

  • Adnan Khan
  • , Ok Sarah Shin
  •  & Woo Joo Kim

• Article
  01 March 2019 | Open Access

  Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose

  • Kate E. Langwig
  • , M. Gabriela M. Gomes
  •  & Marc Lipsitch

• Article
  21 February 2019 | Open Access

  Single Cell Profiling Reveals PTEN Overexpression in Influenza-Specific B cells in Aging HIV-infected individuals on Anti-retroviral Therapy

  • Lesley R. de Armas
  • , Suresh Pallikkuth
  •  & Savita Pahwa

• Article
  07 November 2018 | Open Access

  Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice

  • Whitney R. Baldwin
  • , Jill A. Livengood
  •  & Hansi J. Dean

• Article
  29 June 2018 | Open Access

  Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules

  • Angelika Wagner
  • , Erika Garner-Spitzer
  •  & Ursula Wiedermann

• Article
  26 June 2018 | Open Access

  Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in Egypt

  • Ahmed Kandeil
  • , Jamal S. M. Sabir
  •  & Mohamed A. Ali

• Article
  19 June 2018 | Open Access

  Influenza viral vectors expressing two kinds of HA proteins for bivalent vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 HPAIVs

  • Guangyu Hou
  • , Jinping Li
  •  & Wenming Jiang

• Article
  09 February 2018 | Open Access

  Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory

  • Ana Cárdeno
  • , Maria K. Magnusson
  •  & Anna Lundgren

• Article
  18 January 2018 | Open Access

  Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines

  • Kangwei Xu
  • , Changgui Li
  •  & Junzhi Wang

• Article
  12 January 2018 | Open Access

  Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice

  • Theresa K. Resch
  • , Yuhuan Wang
  •  & Baoming Jiang

• Article
  20 December 2017 | Open Access

  Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken

  • Yun Zhang
  • , Ying Wei
  •  & Yongchang Cao

• Article
  03 October 2017 | Open Access

  High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses

  • David A. Muller
  • , Germain J. P. Fernando
  •  & Mark A. F. Kendall

• Article
  16 August 2017 | Open Access

  Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections

  • Robert C. Mould
  • , Amanda W. K. AuYeung
  •  & Byram W. Bridle

• Article
  12 July 2017 | Open Access

  Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains

  • Ewan P. Plant
  • , Lucy J. Fredell
  •  & Michael J. Cooper

• Article
  13 June 2017 | Open Access

  Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial

  • Surendra K. Sharma
  • , Kiran Katoch
  •  & Rajni Rani

• Article
  24 April 2017 | Open Access

  Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals

  • Narayanaiah Cheedarla
  • , K. Lucia Precilla
  •  & Luke Elizabeth Hanna

• Article
  12 April 2017 | Open Access

  Protective efficacy of Zika vaccine in AG129 mouse model

  • K. Sumathy
  • , Bharathi Kulkarni
  •  & Krishna M. Ella

• Article
  23 March 2017 | Open Access

  Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E

  • Gayeon Won
  • , Irshad Ahmed Hajam
  •  & John Hwa Lee

• Article
  17 March 2017 | Open Access

  The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants

  • Sook-San Wong
  • , Susu Duan
  •  & Richard Webby

• Article
  02 December 2016 | Open Access

  Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study

  • Chi-Ching Chang
  • , Yu-Sheng Chang
  •  & Jin-Hua Chen

• Article
  01 December 2016 | Open Access

  Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine

  • René H. M. Raeven
  • , Jolanda Brummelman
  •  & Bernard Metz

• Article
  16 November 2016 | Open Access

  Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease

  • Jin Hyang Kim
  • , Adrian J. Reber
  •  & Suryaprakash Sambhara

• Article
  24 October 2016 | Open Access

  Implication of vaccination against dengue for Zika outbreak

  • Biao Tang
  • , Yanni Xiao
  •  & Jianhong Wu

• Article
  26 September 2016 | Open Access

  Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation

  • Yi-Sheng Sun
  • , Ya-jing Li
  •  & Han-Ping Zhu

• Article
  11 August 2016 | Open Access

  Mapping B-cell responses to Salmonella enterica serovars Typhimurium and Enteritidis in chickens for the discrimination of infected from vaccinated animals

  • Ibrahim A. Naqid
  • , Jonathan P. Owen
  •  & Kevin C. Gough

• Article
  12 July 2016 | Open Access

  Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice

  • Mable Hagan
  • , Charlene Ranadheera
  •  & Darwyn Kobasa

• Article
  27 May 2016 | Open Access

  ICOS⁺PD-1⁺CXCR3⁺ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination

  • Salah-Eddine Bentebibel
  • , Surender Khurana
  •  & Hideki Ueno

• Article
  25 May 2016 | Open Access

  HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation

  • Adam K. Wheatley
  • , Anne B. Kristensen
  •  & Stephen J. Kent

• Article
  15 April 2016 | Open Access

  Retinoic acid facilitates inactivated transmissible gastroenteritis virus induction of CD8⁺ T-cell migration to the porcine gut

  • Xiaojuan Chen
  • , Chongzhi Tu
  •  & Qian Yang

• Article
  29 February 2016 | Open Access

  An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii

  • Meng-Hooi Shu
  • , NorAziyah MatRahim
  •  & Sazaly AbuBakar

• Article
  25 February 2016 | Open Access

  Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses

  • David A. Muller
  • , Frances E. Pearson
  •  & Mark A. F. Kendall

• Article
  18 August 2014 | Open Access

  A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches

  • Joanna A. Pulit-Penaloza
  • , E. Stein Esser
  •  & Ioanna Skountzou

• Article
  31 July 2013 | Open Access

  High-Resolution Temporal Response Patterns to Influenza Vaccine Reveal a Distinct Human Plasma Cell Gene Signature

  • Alicia D. Henn
  • , Shuang Wu
  •  & Martin S. Zand